Aurobindo Pharma share price
Aurobindo Pharma Ltd. · NSE: AUROPHARMA · Healthcare
Price, one year
Price range
- Open
- ₹1,607.70
- High
- ₹1,608.80
- Low
- ₹1,547.80
- Previous close
- ₹1,610.90
- Volume
- 6.5 L
- Market cap
- ₹90,432 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- 24.6
- Price to book
- 2.4
- Return on equity
- 9.8%
- EPS (TTM)
- ₹64.00
- Book value / share
- ₹658.54
- Debt to equity
- 0.20
- Revenue (TTM)
- ₹34,935 Cr
- Net profit (TTM)
- ₹3,713 Cr
- Sales growth, YoY
- +16.3%
- Profit growth, YoY
- +25.2%
- Operating margin
- 20.3%
- Net margin
- 10.6%
- Sales CAGR, 3 years
- +10.6%
- Profit CAGR, 3 years
- +22.1%
- Promoter holding
- 51.88%
- Promoter shares pledged
- 11.99%
Shareholding pattern
% of shares| Holder | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 51.82 | 51.88 | 51.88 |
| Foreign institutions | 15.24 | 16.38 | 17.41 |
| Domestic institutions | 25.87 | 25.10 | 24.42 |
| Mutual funds | 17.79 | 16.71 | 16.31 |
| Retail and others | 5.74 | 5.36 | 5.02 |
| Promoter pledge | 23.65 | 13.75 | 11.99 |
Futures and options
23 Oct 2026- Lot size
- 550
- Put-call ratio (OI)
- 0.45
- Max pain
- ₹1,660.00
- Highest call OI strike
- 1,800.00
- Highest put OI strike
- 1,700.00
- ATM implied volatility
- 29.3% IV rank 46
- Futures basis
- −0.45%
- Rollover
- 67.4%
Futures open interest, last sessions
| Date | Build-up | Price | OI change |
|---|---|---|---|
| 23 Oct | Long unwinding | −2.38% | −0.40% |
| 22 Oct | Long buildup | +1.60% | +1.38% |
| 21 Oct | Short buildup | −2.85% | +3.30% |
| 19 Oct | Short buildup | −2.52% | +3.90% |
| 16 Oct | Short buildup | −0.74% | +1.91% |
Option figures are for the 27 Oct 2026 expiry.
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 5 Aug 2026.
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,748.00 | −0.57% |
| Divi's LaboratoriesDIVISLAB | ₹8,950.00 | −2.31% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,524.40 | −1.97% |
| Zydus LifesciencesZYDUSLIFE | ₹1,129.40 | −0.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,730.00 | +1.65% |
| CiplaCIPLA | ₹1,338.00 | +0.53% |
| Laurus LabsLAURUSLABS | ₹1,970.00 | −1.62% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,229.50 | −0.77% |
| Mankind PharmaMANKIND | ₹2,212.60 | −2.77% |
| LupinLUPIN | ₹1,928.90 | +0.36% |
Frequently asked questions
What is the share price of Aurobindo Pharma today?
Aurobindo Pharma (NSE: AUROPHARMA) was at ₹1,571.70 on 23 Oct 2026, a change of −2.43% from the previous close.
What are the 52-week high and low of Aurobindo Pharma?
Over the last 52 weeks Aurobindo Pharma traded between ₹1,080.10 and ₹1,740.00 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Aurobindo Pharma?
About ₹90,432 Cr at the latest price, with a P/E of 24.6, a price-to-book of 2.4, a return on equity of 9.8%. Ratios use the company's latest reported results.
Who owns Aurobindo Pharma shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 51.88%, foreign institutions 17.41%, domestic institutions 24.42%.
Is Aurobindo Pharma traded in futures and options?
Yes, AUROPHARMA is in NSE's futures and options segment. The lot size is 550 shares.
Which sector and indices does Aurobindo Pharma belong to?
NSE classifies Aurobindo Pharma under Healthcare; it is a member of Nifty 500.
Follow Aurobindo Pharma with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Start free trial